Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands.

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.

For the first time in five years, the number of children receiving vaccinations from the National Immunisation Programme has increased slightly.

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.